Form 4 for MLAB MESA LABORATORIES INC /CO/
Accepted 2021-07-13 00:00:00 ET · period of report 2021-07-12 · accession 0001228924-21-000046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-13 | 2021-07-12 | MLAB | Sakys John | CFO | M - OptEx | $89.70 | +1,000 | 8,514 | +13% | +$89.7K |
| D | 2021-07-13 | 2021-07-12 | MLAB | Sakys John | CFO | S - Sale+OE | $278.77 | -1,000 | 7,514 | -12% | -$278.8K |
| D | 2021-07-13 | 2021-07-12 | MLAB | Sakys John | CFO | X - OptEx | $0.00 | -1,000 | 30.5K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-12 | M | A | 1,000 | $89.70 | 8,514 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-12 | S | D | 1,000 | $278.77 | 7,514 | D | — | — | (F2) Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on March 1, 2021 |
| 3 | Derivative | Non Qualified Stock Option | 2021-07-12 | X | D | 1,000 | $0.00 | 30,496 | D | $89.70 · 2015-04-01 to 2022-04-01 | 1,000 Common Stock | (F1) 1/7 exercisable on each anniversary date of the 04/01/2014 grant date |